
Continuous Glucose Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Description
Continuous Glucose Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Continuous Glucose Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Continuous Glucose Monitors pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Continuous glucose monitoring system is used for the continuous measurement of blood glucose. The Continuous glucose monitoring system includes an implantable sensor with wireless transmission capability and a monitor.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Continuous Glucose Monitors under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Continuous Glucose Monitors and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Continuous Glucose Monitors under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
132 Pages
- Continuous Glucose Monitors Overview
- Continuous Glucose Monitors - Pipeline Products by Stage of Development
- Continuous Glucose Monitors - Pipeline Products by Territory
- Continuous Glucose Monitors - Pipeline Products by Regulatory Path
- Continuous Glucose Monitors - Pipeline Products by Estimated Approval Date
- Continuous Glucose Monitors - Ongoing Clinical Trials
- Continuous Glucose Monitors Companies - Pipeline Products by Stage of Development
- Continuous Glucose Monitors - Pipeline Products by Stage of Development
- Advanced Biosensors-Ohio LLC Company Overview
- Advanced Medical Electronics Corp Company Overview
- Apollon Inc Company Overview
- Arkal Medical Inc (Inactive) Company Overview
- Azurite Technologies, Inc. (Inactive) Company Overview
- Biovotion AG Company Overview
- CALISTO MEDICAL, INC. (Inactive) Company Overview
- CGM3 Ltd Company Overview
- City, University of London Company Overview
- Columbia University Company Overview
- ConvaTec Group Plc Company Overview
- Cyber Medical Ltd (Inactive) Company Overview
- DexCom Inc Company Overview
- Echo Therapeutics Inc (Inactive) Company Overview
- Eclypia Company Overview
- eLutions Integrated Systems, Inc. Company Overview
- Flowsion A/S Company Overview
- Gili Medical Ltd Company Overview
- Globe Medical Tech Inc (Inactive) Company Overview
- GlucoLight Corporation (Inactive) Company Overview
- Glucometrix AG Company Overview
- GlucoModicum Oy Company Overview
- Glucosense Diagnostics Ltd (Inactive) Company Overview
- GlucoTrack Inc Company Overview
- Glucovation Inc Company Overview
- GluMetrics Inc Company Overview
- Glusense Ltd Company Overview
- GlySens Inc Company Overview
- Guided Therapeutics Inc Company Overview
- Hagar Tech Company Overview
- iGlyko, Inc. (Inactive) Company Overview
- Innovosens AB Company Overview
- Invivosense ASA (Inactive) Company Overview
- I-Sens Inc Company Overview
- KTH Royal Institute of Technology Company Overview
- LEMM Technologies, LLC Company Overview
- Medtronic MiniMed Inc Company Overview
- Metronom Health Inc Company Overview
- MicroTech Medical Inc Company Overview
- mobiLIFE Company Overview
- Nemaura Medical Inc Company Overview
- Newton Photonics Inc Company Overview
- Northwestern University Company Overview
- PKvitality SAS Company Overview
- Purdue University Company Overview
- SD Biosensor Inc Company Overview
- Senseonics Holdings Inc Company Overview
- SensiVida Medical Technologies, Inc. (Inactive) Company Overview
- Socrates Health Solutions, Inc. Company Overview
- Stony Brook University Company Overview
- Swansea University Company Overview
- Tandem Diabetes Care Inc Company Overview
- Tenax Therapeutics Inc Company Overview
- Texas A&M University Company Overview
- Ultradian Diagnostics LLC Company Overview
- University of California Berkeley Company Overview
- University of California Irvine Company Overview
- University of California San Diego Company Overview
- University of South Carolina Company Overview
- University of South Florida Company Overview
- University of Technology Sydney Company Overview
- University of Texas at Arlington Company Overview
- Uxn Co Ltd Company Overview
- VeriTeQ Corporation Company Overview
- Aug 08, 2024: Quebec Expands Public Reimbursement of Abbott's FreeStyle Libre 2 Flash Glucose Monitoring System to More Adults with Diabetes
- Aug 07, 2024: Abbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronic's Insulin Delivery Devices
- Jul 31, 2024: Abbott Issues Voluntary Medical Device Correction for a Small Number of FreeStyle Libre 3 Sensors in the U.S.
- Jul 24, 2024: Abbott Issues Voluntary Medical Device Correction for a Small Number of Freestyle Libre 3 Sensors in the U.S
- Jul 08, 2024: Henry Schein to Webcast Second Quarter 2024 Conference Call on Tuesday, August 6, 2024 at 10:00 a.m. ET
- Jun 27, 2024: Abbott Hosts Conference Call for Second-Quarter Earnings
- Jun 24, 2024: Trinity Biotech to Begin European Pre-pivotal Trial to Optimize Its CGM Sensor
- Jun 20, 2024: Dexcom Expands AID Partnership Into The Netherlands
- Jun 19, 2024: Abbott Diabetes Receives 510(K) Clearance For Libre Rio Continuous Glucose Monitoring System
- Jun 19, 2024: Hagar Announces Published Clinical Data on GWave Technology
- Jun 17, 2024: GlucoModicum ups manufacturing after positive data for needle-free CGM
- Jun 13, 2024: Abbott Medical Receives 510(K) Clearance For Lingo Glucose
- Jun 13, 2024: Medtronic Confirms Global Layoffs
- Jun 11, 2024: FDA approves Abbott's Lingo and Libre Rio glucose monitoring systems
- Jun 03, 2024: Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
- May 21, 2024: Henry Schein to Present at Investor Conferences in June 2024
- May 17, 2024: Senseonics Receives DeNovo Clearance for Eversense AP CGM System
- May 13, 2024: Senseonics and Mercy Collaborate to Improve Diabetes Population Health Management
- May 06, 2024: Abbott Diabetes Care Receives An Additional 510(k) Clearance For FreeStyle Libre 2 Flash Glucose Monitoring System
- May 06, 2024: Abbott Diabetes Care Receives An Additional 510(k) Clearance For FreeStyle Libre 3 Continuous Glucose Monitoring System
- Apr 30, 2024: Glutality powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology
- Apr 19, 2024: Lee's Pharmaceutical Notice of Annual General Meeting
- Apr 08, 2024: Draper Drives Growth Strategy with Appointment of Carrie George as Chief Financial Officer
- Apr 03, 2024: Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024
- Mar 26, 2024: Going Beyond Blood Glucose Monitoring: How CGM's Panoramic Perspective Redefines Diabetes Management
- Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
- Mar 06, 2024: Know Labs' Non-Invasive Glucose Monitor Achieves 11.1% MARD in Latest Clinical Research Study
- Mar 06, 2024: Tandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029
- Mar 04, 2024: Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
- Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
- Feb 13, 2024: Insulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference
- Feb 09, 2024: Invitation to Senzime's Fourth Quarter 2023 Report Presentation
- Feb 06, 2024: Dexcom launches real-time CGM solution Dexcom ONE+ in Europe
- Jan 17, 2024: Huons Donates 6,000 Continuous Glucose Monitors To Type 1 Diabetes Patients
- Jan 11, 2024: Veri Releases New Metabolic Health Program
- Jan 03, 2024: Henry Schein to Present at J.P. Morgan's Healthcare Investor Conference
- Nov 12, 2023: Mubadala Health Kicks Off Two-Day Diabetes Conference in Abu Dhabi
- Nov 07, 2023: Henry Schein to Present at Upcoming Investor Conferences in November 2023
- Oct 23, 2023: Invitation to Senzime's Third Quarter 2023 Report Presentation
- Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023
- Oct 10, 2023: Tandem Diabetes Care to Announce Third Quarter 2023 Financial Results on November 1, 2023
- Sep 19, 2023: Abbott and Weightwatchers Connected App Experience Is Now Available for People Living With Diabetes
- Sep 19, 2023: Lifecare - Sanofi Product Development Agreement Update
- Sep 11, 2023: Nemaura Medical Completes 100 Patient Study for Sugarbeat 24-Hour Wear and Reports Interim Results
- Sep 05, 2023: Henry Schein to Present at Investor Conferences in September 2023
- Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.